Filiz KOÇ, Hürü Rabia GÜLEÇ, Hakan GELİNCİK, ATIL BİŞGİN

MELAS AİLESİ: Klinik - Genetik Korelasyon

MELAS (Mitokondriyal Ensefalopati Laktik Asidoz Stroke Benzeri Epizodlar), multisistemik bir kas hastalığıdır. Klinik bulgular miyopati, göz bulguları, sensorinöral işitme kaybı, epilepsi, baş ağrısı, inme, endokrinopatiler ile prezente olur. Hastalıktan sorumlu mutasyonlar sıklık sırasına göre A3243G, T3271C, C3093G, A3252G, C3256T, A3260G, T3291C, T3308C, A13514G’dır. Bu makalede, farklı semptomlara sahip A3243G mutasyonu tespit edilen bir aileden altı MELAS’lı olgu, hastalığın klinik bulgularına dikkat çekilmek üzere sunulmuştur.

MELAS FAMILY: Clinical - Genetic Correlation

MELAS (Mitochondrial Encephalopathy Lactic Acidosis and Stroke like episodes) is a multisystemic muscle disease. Clinical findings are presented with myopathy, eye findings, sensorineural hearing loss, epilepsy, headache, stroke, endocrinopathies. The mutations responsible for the disease are A3243G, T3271C, C3093G, A3252G, C3256T, A3260G, T3291C, T3308C, A13514G, respectively. In this article, six patients with MELAS from a family with different symptoms A3243G mutation are presented to draw attention to the clinical manifestations of the disease.

PDF

___

1. Panades-de Oliveira L, Montoya J, Emperador S, et al. A novel mutation in the mitochondrial MT-ND5 gene i n a f amily w ith M ELAS. T he r elevance of genetic analysis on targeted tissues. Mitochondrion 2020; 50: 14-8.
2. Sweeney MG, Bundey S, Brockington M, et al. Mitochondrial myopathy associated with sudden death i n young adults and a n ovel mutation i n t he mitochondrial DNA leucine transfer RNA(UUR) gene. Q J Med 1993; 86: 709-13.
3. Lin J, Zhao CB, Lu JH, et al. Novel mutations m.3959G>A and m.3995A>G in mitochondrial gene MT-ND1 associated with MELAS. Mitochondrial DNA 2014; 25: 56-62.
4. Hsu YR, Yogasundaram H, Parajuli N, et al. MELAS syndrome and cardiomyopathy: linking mitochondrial function to heart failure pathogenesis. Heart Fail Rev 2016; 21: 103-16.
5. Koç F, Özeren A, Sarıca Y, et al. Genç inme nedeni olarak MELAS sendromu. Türk Serebrovasküler Hastalıklar Dergisi. 2004; 10: 135-8.
6. Cheldi A, Ronchi D, Bordoni A, et al. POLG1 mutations and stroke like episodes: a distinct clinical entity rather than an atypical MELAS syndrome. BMC Neurol 2013; 13: 8.
7. Kaufmann P, Engelstad K, Wei Y, et al. Natural history of MELAS associated with mitochondrial DNA m.3243A>G genotype. Neurology 2011; 77: 1965-71.
8. Murakami H, Ono K. MELAS: Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke- Like Episodes. Brain Nerve 2017; 69: 111-17.
9. Sinnecker T, Andelova M, Mayr M, et al. Diagnosis of adult-onset MELAS syndrome in a 63-year-old patient with suspected recurrent strokes - a case report. BMC Neurol 2019; 19 : 91.
10. Hongo Y, Kaneko J, Suga H, et al. A cluster of disseminated small cortical lesions in MELAS: its distinctive clinical and neuroimaging features. J Neurol 2019:266: 1459- 72.
11. Thambisetty M, Newman NJ. Diagnosis and management of MELAS. Expert Rev Mol Diagn 2004; 4: 631-44.
12. Wang YX, Le WD. Progress in Diagnosing Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like Episodes. Chin Med J (Engl) 2015; 128: 1820-5.
13. El-Hattab AW, Adesina AM, Jones J, Scaglia F. MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options. Mol Genet Metab 2015; 116: 4-12.